Skip to main content

Uplizna 100 mg/10 mL injection Images

Generic Name: inebilizumab

This medication has been identified as Uplizna 100 mg/10 mL injection. It is supplied by Viela Bio, Inc.

Uplizna is used in the treatment of Immunoglobulin G4-Related Disease; Neuromyelitis Optica Spectrum Disorder and belongs to the drug class selective immunosuppressants. Uplizna 100 mg/10 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Uplizna 100 mg/10 mL injection medicine

Uplizna

Generic Name
inebilizumab
Strength
100 mg/10 mL injection
Availability
Prescription only
Drug Class
Selective immunosuppressants
CSA Schedule
Not a controlled drug
Labeler / Supplier
Viela Bio, Inc.
National Drug Code (NDC)
72677-0551 (Discontinued)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.